Results 91 to 100 of about 467,321 (167)
Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective
Andrew D Mihalek,1 Christopher D Scott,2 Sula Mazimba3 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, VA, USA; 2Division of Thoracic Surgery, Department of Surgery, University of ...
Mihalek AD, Scott CD, Mazimba S
doaj
Purpose: In cavernous smooth muscle nitric oxide (NO) activates soluble guanylate cyclase, which catalyzes the synthesis of cyclic guanosine 3′,5′-monophosphate, leading to smooth muscle relaxation, increased blood flow and penile erection.
Rees, Rowland W. +7 more
core +1 more source
The Role of Vericiguat in Early Phases of Anterior Myocardial Infarction: A Potential Game-Changer?
Anterior myocardial infarction is a critical condition with significant implications for cardiac function and patient prognosis. Despite advancements in reperfusion therapies, optimizing recovery during the early phases of myocardial infarction remains ...
Federico Cacciapuoti +8 more
doaj +1 more source
Soluble Guanylate Cyclase Generation of cGMP Regulates Migration of MGE Neurons
Here we have provided evidence that nitric oxide-cyclic GMP (NO-cGMP) signaling regulates neurite length and migration of immature neurons derived from the medial ganglionic eminence (MGE).
Mandal, Shyamali +4 more
core +1 more source
the present study, we showed that 3-(5'-hydroxymethyl-2'- furyl)-1-benzyl indazole (YC-1), a nitric oxide (NO)- independent activator of soluble guanylate cyclase, could potentiate H2O2-induced inhibition of platelet aggregation and increase of platelet ...
Wu, Chin-Chung; Kuo, Sheng-Chu; Lee, Fang-Yu; Teng, Che-Ming +1 more
core
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
Alterations of the nitric oxide receptor, soluble guanylate cyclase (sGC) may contribute to the pathophysiology of pulmonary arterial hypertension (PAH). In the present study, the expression of sGC in explanted lung tissue of PAH patients was studied and
Muller, D. +16 more
core
Targeting the NO–sGC–cGMP Pathway: Mechanisms of Action of Vericiguat in Chronic Heart Failure
The recent advancements in the medical management of patients with chronic heart failure with reduced ejection fraction (HFrEF) is the soluble guanylate cyclase (sGC) stimulator, vericiguat.
Tine Bajec, Gregor Poglajen
doaj +1 more source
Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
AimsThe clinical outcomes for patients with worsening chronic heart failure (WCHF) remain exceedingly poor despite contemporary evidence‐based therapies, and effective therapies are urgently needed.
Shah S +15 more
core
A B S T R A C T The relationship between the subcellular distribution of guanylate cyclase and tissue guanosine-3',5'-cyclic monophosphate (cGMP) levels was investigated in rat testes after surgically induced unilateral cryptorchidism ...
W Austin Spruill +2 more
core
Activation of cGMP synthesis leads to vasodilation, and is an important mechanism in clinical treatment of angina, heart failure, and severe peripheral and pulmonary hypertension.
Gileadi, Opher +2 more
core +1 more source

